CGON compared with DNTH: revenue, margins and what each company keeps, and the suppliers and customers both name

CGONCG Oncology, Inc.

Mkt capRevenueRevenue

DNTHDianthus Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

CGONCG Oncology, Inc.

DNTHDianthus Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CGON

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±14.5%▲+3.36%×0.23

May 8 '26±9.9%▲+0.64%×0.06

Q1 FY26±10.7%▲+4.79%×0.45

Nov 14 '25±10.0%▲+8.61%×0.86

DNTH

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.7%▲+1.90%×0.20

May 6 '26±7.6%▲+0.20%×0.03

= impliedCGON realized, solidDNTH realized, hatchedOne scale, both sides: full bar = 22%× = |realized| ÷ impliedSource: market data

Q1 FY26

±11.9%

▲+21.52%

×1.81

Jan 12 '26±9.0%▲+2.44%×0.27

CGONCG Oncology, Inc.

62.03▼−4.10%· post 62.03· delayed

Mkt cap$5.7BRevenue$1MQ2 FY26Revenue—

DNTHDianthus Therapeutics, Inc.

82.32▼−0.08%· post 82.32· delayed

After hoursNov 2 '26delayed

Mkt cap$4.6BRevenue$761,000Q2 FY26Revenue$6MFY24

Compare

After hoursNov 2 '26delayed

CGONCG Oncology, Inc.

DNTHDianthus Therapeutics, Inc.

62.03▼−4.10%post 62.03delayed

Price

82.32▼−0.08%post 82.32delayed

$5.7B

Mkt cap

$4.6B

Q2 FY26$1M

Revenue

$761,000Q2 FY26

—

Revenue

$6MFY24

CGON62.03▼−4.10%vsDNTH82.32▼−0.08%After hoursNov 2 '26delayed